Use of corticotropin releasing factor antagonists and related compositions
The present invention relates to compositions and methods of achieving a therapeutic effect including, the treatment or prevention of Syndrome X in an animal, preferably a mammal including a human subject or a companion animal, using a corticotropin releasing factor (CRF) antagonist alone or together with a glucocorticoid receptor antagonist.
Pfizer Inc
A A A A A A A A A A A A A A
A61K A61P A61K A61K A61K A61K A61K A61K A61K A61K A61K A61P A61K A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Yuhpyng Liang Ernest S.
Chen Hamanaka